Centessa Pharmaceuticals (CNTA) Amortizatization of Intangibles (2020 - 2026)
Centessa Pharmaceuticals (CNTA) reported Amortizatization of Intangibles of -$811000.0 for Q1 2026, down 138.95% year-over-year from $2.1 million in Q1 2025, and down 81.43% on a QoQ basis from -$447000.0 in Q4 2025.
Centessa Pharmaceuticals (CNTA) has 3 years of Amortizatization of Intangibles data on file, last reported at -$811000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 138.95% year-over-year to -$811000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 million (down 152.4% YoY) and the FY2025 annual result came in at $1.8 million, changed N/A from the prior year.
- Amortizatization of Intangibles retreated to -$811000.0 in Q1 2026 per CNTA's latest filing, from -$447000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.1 million in Q1 2025 and bottomed at -$811000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Centessa Pharmaceuticals | 6.12 Bn | 6.12 Bn | - | -811,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -811,000.00 |
| Mar 31, 2026 | -811,000.00 |
| Dec 31, 2025 | -447,000.00 |
| Dec 31, 2025 | -447,000.00 |
| Sep 30, 2025 | 114,000.00 |
| Sep 30, 2025 | 114,000.00 |
| Jun 30, 2025 | 53,000.00 |
| Jun 30, 2025 | 53,000.00 |
| Mar 31, 2025 | 2.08 Mn |
| Mar 31, 2025 | 2.08 Mn |
| Sep 30, 2020 | 78,000.00 |
| Sep 30, 2020 | 78,000.00 |
| Jun 30, 2020 | 72,000.00 |
| Jun 30, 2020 | 72,000.00 |